Furthermore, we identified the Reelin-LRP8 signaling pathway as a key regulatory mechanism in aggressive brain metastatic breast cancer, with LRP8 enhancing CDC42 activation to promote filopodia formation, dependent on Reelin. Here, RELN is linked to breast cancer.